In other words, this interesting discovery establishes a link among Nav1.7, Nav1.8 and Nav1.9 in the pain signaling pathway and provides a helpful strategy for therapeutic development for Nav1.7-related CIP. This evidence concerns the gene SCN9A and hereditary sensory and autonomic neuropathy.